Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion

Netherlands Journal of Medicine

Volumn 65, Issue 2, 2007, Pages 65-70

  Logtenberg, S J J ^a   van Ballegooie, E ^a   Israel Bultman H ^a   van Linde, A ^a   Bilo, H J G ^a  

^a ISALA HOSPITAL   (Netherlands)

Author keywords

CIPII; Diabetes mellitus; Intensive insulin treatment; Quality of life

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INFUSION PUMP; LONGITUDINAL STUDY; MALE; MENTAL HEALTH; NETHERLANDS; PATIENT ASSESSMENT; PATIENT SATISFACTION; PREVALENCE; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; WELLBEING; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCEMIC INDEX; HEALTH STATUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; INSULIN INFUSION SYSTEMS; MALE; NETHERLANDS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE;

EID: 33847421875     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nathan DM, Dunn FL, Bruch J, et al. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycaemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Am J Med 1996;100:412-7.
2. Schade DS, Eaton RP, Friedman NM, Spencer WJ. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diabetologia 1980;19:35-9.
3. Selam JL, Bergman RN, Raccah D, Jeandidier N, Lozano J, Charles MA. Determination of portal insulin absorption from peritoneum via a novel non isotopic method. Diabetes 1990;39:1361-5.
4. Wan CK, Giacca A, Matsuhisa M, et al. Increased responses of glucagon and glucose production to hypoglycaemia with intraperitoneal versus subcutaneous insulin treatment. Metabolism 2000;49:984-9.
5. Jeandidier N, Pinget M, Keipes M, Louy S, Vetter A, Reville P. Comparison intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study. Transplant Proc 1992;24:948-9.
6. Saudek CD, Duckworth WC, Giobbie-Hurder A, et al. Implantable insulin pump vs. multiple-dose insulin for non-insulin dependent diabetes mellitus. JAMA 1996;276:1322-7.
7. Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group. Diabetes Care 1997;20:59-63.
8. Selam JL, Micossi P, Dunn FL, Nathan DM. Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care 1992; 15:877-85.
9. Haardt MJ, Selam JL, Slama G, et al. A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes. Diabetes Care 1994;17:847-51.
10. Hanaire-Broutin H, Broussolle C, Jeandidier N, et al. for the EVADIAC Study Group: Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM: A multicenter study. Diabetes Care 1995;18:388-92.
11. Snoek FJ. Barriers to good glycaemic control: the patient's perspective. Int J Obes Relat Metab Disord 2000;24 Suppl 3:S12-20.
12. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
13. Rosenthal MJ, Fajardo M, Gilmore S, Morley JE, Naliboff BD. Hospitalisation and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care 1998;21:231-5.
14. Selam JL. External and implantable insulin pumps: current place in the treatment of diabetes. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2): S333-S340.
15. Renard E, Bouteleau S, Jacques-Apostol D, et al. Insulin underdelivery from implanted pumps using peritoneal route: determinant role of insulin-pump compatibility. Diabetes Care 1996;19:812-7.
16. Renard E, Souche C, Jacques-Apostol D, et al. Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care 1999;22:1371-2.
17. Schaepelynck-Belicar P, Dufaitre-Patouraux L, Lassmann-Vague V. What could be the reasons for giving up the implanted pump treatment? Diabetes Metab 2005;31:87-9.
18. DeVries JH, Eskes SA, Snoek FJ, et al. Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay. Diabet Med 2002;19:496-501.
19. Ware Jr JE, Kosinski M, Keller S. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
20. World Health Organization: Regional Office for Europe. Well-Being Measures in Primary Health Care: The DepCare Project. Consensus meeting, Stockholm, 1998.
21. Ware JE, Kosinski M, Keller SD. How to score the SF-12 Physical and Mental Health Summary scales. 2nd ed. Boston: The Health Institute, New England Medical Center, 1995.
22. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-8.
23. Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004;32:15-6.
24. Shea S, Skovlund S, Bech P, Kalo I, Home PD. Routine assessment of psychological well-being in people with diabetes in primary care - validation of the WHO-5 Well-being Index in six countries. Presentation at the 18th International Diabetes Federation Congress, August 24-29th 2003, Paris. Diabetologia 2003;46 (2 Suppl):A88 [no 245]
25. Bradley C. Diabetes treatment satisfaction questionnaire. In: Bradley C. editor. Handbook of Psychology and Diabetes. Chur: Harwood Academic Publishers; 1994. p.111-32.
26. Pouwer F, Snoek FJ, van der Ploeg HM, Heine RJ, Brand AN. A comparison of the standard and the computerized versions of the Well-being Questionnaire (WBQ) and the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Qual Life Res 1998;7:33-8.
27. Hoogma RP, Spijker AJ, van Doorn-Scheele M, et al. Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth J Med 2004;62:383-7.
28. Rijken M, van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning. Qual Life Res 2005;14:45-55.
29. Rakovac I, Gfrerer RJ, Habacher W, et al. Screening of depression in patients with diabetes mellitus. Diabetologia 2004;47:1469-70.
30. Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomised controlled trial. Diabet Med 2000;17:762-70.
31. Pouwer F, Snoek FJ, Heine RJ. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire. Diabetes Care 1998;21:2039.
32. Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 1999;22:530-2.
33. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997;20:562-7.
34. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238-43.
35. Rose M, Burkert U, Scholler G, Schirop T, Danzer G, Klapp BF. Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 1998;21:1876-85.